NCT01639157View on ClinicalTrials.gov

Impact of Buspirone Maintenance on the Reinforcing Effects of Cocaine

NACompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions
Cocaine Use Disorders
Interventions
DRUG

Buspirone

Subjects will be maintained on oral buspirone (10 mg administered 3 times daily) for 6 days each during the study in random order.

DRUG

Placebo

Subjects will be maintained on oral placebo (0 mg administered 3 times daily) for 6 days each during the study in random order.

Trial Locations (1)

40536

University of Kentucky Medical Center, Lexington

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

William Stoops

OTHER

NCT01639157 - Impact of Buspirone Maintenance on the Reinforcing Effects of Cocaine | Biotech Hunter | Biotech Hunter